Clinical Trial Update: Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide [Phase 4]

View source ↗

Summary

Phase 4 multicenter trial evaluating pharmacokinetic-guided docetaxel in combination with cyclophosphamide for breast cancer; study completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Breast Cancer, Breast Cancer Female | Phase 4 | Status: COMPLETED | Results posted: 2018-10-18